Literature DB >> 23240460

The effect of using estrogens in the light of scientific research.

Marta Królik1, Halina Milnerowicz.   

Abstract

Estrogens are female sex hormones, belonging to a group of steroid hormones, derivatives of cholesterol. These hormones can be divided in terms of origin: natural and synthetic. Biologically, the most active is estradiol (E2). Estrogens are responsible for the development of tertiary sexual characteristics and a number of metabolic processes. In our environment there are many substances, metals and toxins which can mimic the biological functions of estrogens. Due to its characteristics, it can induce cell proliferation and stimulate tumor development. Estrogens are subject to a complex metabolism that, inadequately controlled, can lead to toxic derivatives. Catecholestrogens quinones (CE-Q) interact with DNA and form depurinating adducts disturbing cellular processes. By affecting cell proliferation, it can stimulate the formation of mutation and carcinogenesis, by stimulating the production of free radicals exhibiting genotoxicity. Estrogens are mostly used in hormone replacement therapy and hormonal contraception. There are three main sources of administration of preparations containing estrogen: oral, vaginal and percutaneous. The latter two are characterized by a lack of a so-called "first pass effect". Numerous studies carried out on estrogens (both natural and synthetic) demonstrate the possibility of their detrimental function on the human body. Through its impact on clotting factors, it increases the risk of thrombosis and is considered to participate in the formation of cancer of the breast and uterus. That is why the introduction of estrogen therapy should always be preceded by a careful assessment of individual circumstances and the balance between potential benefits and risks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240460

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  10 in total

1.  MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells.

Authors:  Jun Lin; Li Wang; Jie Gao; Shiguang Zhu
Journal:  Exp Ther Med       Date:  2017-07-24       Impact factor: 2.447

2.  Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Authors:  Shahla H Al-Saqi; Kerstin Uvnäs-Moberg; Aino F Jonasson
Journal:  Post Reprod Health       Date:  2015-05-19

3.  Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.

Authors:  Jian Chen; Ruanling Hou; Xing Zhang; Yu Ye; Yong Wang; Jing Tian
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

4.  Estrogen suppresses adipogenesis by inhibiting S100A16 expression.

Authors:  Rihua Zhang; Dongming Su; Weidong Zhu; Qiong Huang; Menglan Liu; Yi Xue; Yuanyuan Zhang; Dong li; Allan Zhao; Yun Liu
Journal:  J Mol Endocrinol       Date:  2014-04-28       Impact factor: 5.098

5.  Decreased Expression of GPER1 Gene and Protein in Goiter.

Authors:  Raquel Weber; Ana Paula Santin Bertoni; Laura Walter Bessestil; Ilma Simoni Brum; Tania Weber Furlanetto
Journal:  Int J Endocrinol       Date:  2015-03-12       Impact factor: 3.257

6.  Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice.

Authors:  Zhuhong Zhang; Haifang Li; Mugimane G Manjanatha; Tao Chen; Nan Mei
Journal:  Genes Environ       Date:  2015-07-30

7.  Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.

Authors:  Ranjith Kumavath; Manan Azad; Pratap Devarapalli; Sandeep Tiwari; Shreya Kar; Debmalya Barh; Vasco Azevedo; Alan Prem Kumar
Journal:  Bioinformation       Date:  2016-10-10

8.  Effect of interactions between APOE and ESR1 polymorphisms on cognitive functions in postmenopausal women.

Authors:  Jarosław Pinkas; Iwona Bojar; Mariusz Gujski; Beata Sarecka-Hujar; Alfred Owoc; Dorota Raczkiewicz
Journal:  Arch Med Sci       Date:  2018-12-31       Impact factor: 3.318

9.  Microscopic colitis and reproductive factors related to exposure to estrogens and progesterone.

Authors:  Bodil Roth; Jonas Manjer; Bodil Ohlsson
Journal:  Drug Target Insights       Date:  2013-10-07

10.  Mortality and years of life lost due to breast cancer attributable to physical inactivity in the Brazilian female population (1990-2015).

Authors:  Diego Augusto Santos Silva; Mark Stephen Tremblay; Maria de Fatima Marinho de Souza; Maximiliano Ribeiro Guerra; Meghan Mooney; Mohsen Naghavi; Deborah Carvalho Malta
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.